Clinical
Pharmacists Are Critical Players in Opioid Use Disorder Care
Pharmacist opioid use disorder training expands access to care, empowering pharmacists to prescribe buprenorphine ...
AUGUST 6, 2026
Why Advanced IBD Therapies Fail
The term "treatment-refractory" frequently masks a more complex reality driven by structural bowel damage, ...
AUGUST 3, 2026
CMS Closes Tardive Dyskinesia Screening Gap for Medicare Plans
CMS Medicare Rule 2026 urges clinicians to screen antipsychotic patients for tardive dyskinesia, advancing ...
JULY 31, 2026
Tools to Assess CV Risk Are Unmet Need in MASLD
Commonly used cardiovascular risk assessment tools showed a poor ability to predict cardiac events in patients with ...
JULY 29, 2026
Treating CD in Patients With Cancer: Anti-TNF or IL-23p19 Therapy?
Treating active Crohn's disease in patients undergoing therapy for solid-organ malignancy forces clinicians to ...
JULY 27, 2026
IV Iron Infusions Improve Survival for Hospitalized Patients With Sepsis
IV iron in sepsis improves survival for patients with iron deficiency anemia, new research shows.
JULY 27, 2026
Persistent Iron Deficiency Signals Missed Opportunities for Intervention
Iron deficiency study reveals slow resolution rates, highlighting underdiagnosis and need for improved IV iron ...
JULY 27, 2026
Navigating the New Complexity of Multiple Myeloma Treatment
Multiple myeloma treatment evolves with quadruplet induction, CAR-T therapy, and BiTE sequencing redefining ...
JULY 26, 2026
New ASPEN Guidelines Address Malnutrition Risk in HNC
Head and neck cancer nutrition guidelines help clinicians manage malnutrition, support treatment, and improve ...
JULY 25, 2026
Daraxonrasib Doubles Survival in Metastatic Pancreatic Cancer
Daraxonrasib doubles survival in metastatic pancreatic cancer—practice-changing results with new supportive ...
JULY 23, 2026
Management of Chorea In Huntington Disease
Huntington disease treatment overview, highlighting VMAT2 inhibitors, multidisciplinary care, and advances in ...
JULY 22, 2026
Taking a BiTE out of Multiple Myeloma
Bispecific antibodies reshape multiple myeloma treatment, improving response rates and expanding outpatient care ...
JULY 22, 2026
